ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Podcasts

Podcasts

The American Society of Clinical Oncology (ASCO) issued the first guidance, a provisional clinical opinion (PCO), on second-line hormonal therapy for

In this interview we discuss the phase III trial of aldoxorubicin in patients with advanced soft-tissue sarcoma, which showed improved efficacy and reduced toxicity over doxorubicin.

In this interview we discuss new data on the use of radiotherapy in cancer patients with brain metastases.

In this interview we discuss the effect of the gut microbiome on responses and survival outcomes in metastatic melanoma patients treated with anti–PD-1 immunotherapies.

In this interview we discuss how relapse in multiple myeloma manifests and treatment options for relapsed/refractory patients.

As part of our coverage of the 2017 ASCO Annual Meeting, we discuss homologous recombination deficiency in ovarian cancer and PARP inhibitors.

Ahead of the 2017 ASCO Annual Meeting, we discuss the discontinuation of TKIs in some chronic myeloid leukemia patients.

Pages

Subscribe to Podcasts on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.